ThermoGenesis Corp. (KOOL)
-NasdaqCM 1.22 
0.05(3.94%) Jun 17, 3:59PM EDT
| Prev Close: | 1.27 |
|---|
| Open: | 1.27 |
|---|
| Bid: | 0.98 x 100 |
|---|
| Ask: | 10.45 x 200 |
|---|
| 1y Target Est: | 4.25 |
|---|
| Beta: | 2.23 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 1.21 - 1.29 |
|---|
| 52wk Range: | 0.61 - 1.43 |
|---|
| Volume: | 32,623 |
|---|
| Avg Vol (3m): | 28,397 |
|---|
| Market Cap: | 20.17M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.09 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- ThermoGenesis Announces New AXP(R) Customer in the United KingdomGlobeNewswire(Wed, Jun 12)
- THERMOGENESIS CORP Files SEC form 8-K, Other EventsEDGAR Online(Mon, Jun 10)
- THERMOGENESIS CORP Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Tue, May 28)
- THERMOGENESIS CORP FinancialsEDGAR Online Financials(Tue, May 21)
- ThermoGenesis' CEO Discusses F3Q2013 Results - Earnings Call Transcriptat Seeking Alpha(Tue, May 14)
- ThermoGenesis Reports Third Quarter Fiscal 2013 ResultsGlobeNewswire(Tue, May 14)
- THERMOGENESIS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibiEDGAR Online(Tue, May 14)
- Q3 2013 Thermogenesis Earnings Release - After Market CloseCCBN(Tue, May 14)
- ThermoGenesis Announces Registration Approval of AXP in ChinaGlobeNewswire(Wed, May 8)
- ThermoGenesis Corp. to Announce Third Quarter Fiscal 2013 Results on May 14, 2013GlobeNewswire(Tue, May 7)
- THERMOGENESIS CORP Files SEC form 8-K, Other EventsEDGAR Online(Fri, Apr 12)
- ThermoGenesis Announces New AXP(R) Customer in PortugalGlobeNewswire(Mon, Apr 1)
- CFO Moves: PPG, ThermoGenesis, Accentureat The Wall Street Journal(Thu, Mar 28)
- ThermoGenesis Names Dan Bessey Chief Financial OfficerGlobeNewswire(Thu, Mar 28)
- THERMOGENESIS CORP Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Thu, Mar 28)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1.15 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
ThermoGenesis Corp. designs, develops, and commercializes devices and disposable tools for the processing, storage, and administration of cell and tissue therapies used in the practice of regenerative medicine worldwide.
View More